Skip to content
Sign in
StableHealthReported 2026-11-16 19:45

Medtronic to acquire Contego Medical, expanding access to next-generation carotid therapies

Medtronic announced its intent to acquire Contego Medical, a privately held medical device company focused on carotid artery disease and peripheral thrombectomy, for $380 million. The deal adds Contego's Neuroguard IEP Direct System and Excipio thrombectomy devices to Medtronic's portfolio, broadening patient access to integrated embolic protection technologies.

Why it matters. The acquisition combines Medtronic's peripheral vascular expertise with Contego's next-generation carotid revascularization and embolic protection technologies, potentially improving stroke outcomes and expanding treatment options for…

01

Who and what it touches

Electrophysiology The…part ofcardiac devicesmanufacturesGalwaylocated inGovernment regulationregulatory exposureHealthcare technologyoperates inInsulin pumpsusesPatient monitoring sy…producesContego Medicalinvests inMedtronic

Into Medtronic

From Medtronic

Each line is a relation with evidence behind it, drawn in the direction it points. A line shows that two things are connected, not how far this change reaches.

02

Evidence

  • PPR Newswire news releasesCompany2026-11-16 19:45
    Contego's recently FDA-approved Neuroguard IEP*™ Direct System
    View source
  • MMedTech DiveMedia2026-11-16 23:56
    View source